Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 22
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07274852 - 1. fázisNot yet taking people in KínaNK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 10
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07318636 - 2/3. fázisNot yet taking people in KínaA Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 720
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07318883 - 4. fázisTaking peoplePostoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT07320105 - 1/2. fázisTaking peopleStudy of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 54
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT05978284 - 1/2. fázisTaking peopleStudy of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06903377 - 1/2. fázisTaking peopleStudy of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06938880 - 1/2. fázisTaking peopleZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
- Where
- Guanzhou
- Életkor
- 18 év to 70 év
- People
- 350
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07038096 - 2. fázisTaking peopleAdaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
- Where
- Chengdu, Guangzhou
- Életkor
- 28 év to 75 év
- People
- 115
- Run by
- Guangdong Association of Clinical Trials
See details and how to joinNCT07120698 - 3. fázisTaking peopleStudy Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 420
- Run by
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07189455 - 2. fázisTaking peopleLow-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Sichuan University
See details and how to joinNCT06877299 - No phaseTaking peopleSleeve Lobectomy Following Neoadjuvant Therapy in NSCLC
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 400
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07135856 - 2. fázisTaking peopleAdebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy
- Where
- Xi'an
- Életkor
- 18 év to 75 év
- People
- 32
- Run by
- Tang-Du Hospital
See details and how to joinNCT07141264 - 2. fázisNot yet taking people in KínaA Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 28
- Run by
- Zhijie Wang
See details and how to joinNCT07307443 - 2. fázisNot yet taking people in KínaGolidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 16
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07303881 - 2. fázisTaking peopleFurmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases
- Where
- Cangzhou, Tianjin
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07304739 - No phaseTaking peopleDifferentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
- Where
- Beijing, Chengdu, Foshan, Guangzhou, Shanghai, Wuhan
- Életkor
- 18 év to 80 év
- People
- 3000
- Run by
- ChromX Health
See details and how to joinNCT06518655 - 2. fázisTaking peopleSunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 34
- Run by
- Fudan University
See details and how to joinNCT07117890 - No phaseTaking peopleExploratory Trial of Navigational Bronchoscopy-Guided Cryoablation in Lung Cancer Treatment
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 40 worldwide
- Run by
- Tianjin Puli Ark Medical Technology Co., Ltd.
See details and how to joinNCT07301411 - 1/2. fázisTaking peopleA Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 248
- Run by
- Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT06512051 - 2. fázisNot yet taking people in KínaGarsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 69
- Run by
- Sun Yat-sen University
See details and how to joinNCT07294261 - 2. fázisTaking peopleA Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 120
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07003321 - 2. fázisTaking peopleA Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer(NSCLC) Patients
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 240
- Run by
- Shenyang Sunshine Pharmaceutical Co., LTD.
See details and how to joinNCT07171606 - 1. fázisTaking peopleJMT106 Injection in the Treatment of Advanced Solid Tumors
- Where
- Zhejiang
- Életkor
- 18 év and over
- People
- 200
- Run by
- Shanghai JMT-Bio Inc.
See details and how to joinNCT07275073 - 2. fázisTaking peoplePhase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer
- Where
- Chengdu, Chongqing, Guiyang, Nanchong, Wuhan
- Életkor
- 18 év to 75 év
- People
- 114
- Run by
- Sichuan University
See details and how to joinNCT06121505